{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T19:33:38Z","timestamp":1782934418033,"version":"3.54.5"},"reference-count":48,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T00:00:00Z","timestamp":1732492800000},"content-version":"vor","delay-in-days":24,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004085","name":"Ministry of Education, Science and Technology","doi-asserted-by":"publisher","award":["2017R1A6A1A03015713"],"award-info":[{"award-number":["2017R1A6A1A03015713"]}],"id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["American J Rep Immunol"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:sec><jats:title>Problem<\/jats:title><jats:p>The imbalance in the Th17\/Regulatory T (Treg) cell ratio is associated with recurrent pregnancy loss (RPL). This study aimed to determine a cut\u2010off for the Th17\/Treg cell ratio to predict pregnancy outcomes in RPL and evaluate the effectiveness of intravenous immunoglobulin (IVIG) based on this cut\u2010off value.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method of Study<\/jats:title><jats:p>This retrospective cohort study included 49 idiopathic RPL and 75 controls. The subgroups of IL\u201017<jats:sup>+<\/jats:sup> T cell to Foxp3<jats:sup>+<\/jats:sup> T cell ratios in peripheral blood were measured using flow cytometry. The cut\u2010off values of Th17\/Treg cell ratios were determined by the ROC curve to distinguish between RPL and controls. The IVIG treatment effectiveness in pregnancy outcome was compared between high\u2010 and low\u2010ratio groups. Pearson correlation assessed the Th17\/Treg cell ratio's relationship with NK cell cytotoxicity (NKC), NK cell percentage, and Th1\/Th2 cell ratio.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Using the ROC curve, we identified six Th17\/Treg cell ratio markers with diagnostic value, and the following two, CD3<jats:sup>+<\/jats:sup>IL\u201017<jats:sup>+<\/jats:sup> T cell\/CD3<jats:sup>+<\/jats:sup>Foxp3<jats:sup>high<\/jats:sup> T cell ratio (sensitivity at 97%) and CD4<jats:sup>+<\/jats:sup>IL\u201017<jats:sup>+<\/jats:sup> T cell\/CD3<jats:sup>+<\/jats:sup>Foxp3<jats:sup>high<\/jats:sup> T cell ratio (specificity at 93.61%), showed the highest statistical significance in diagnosing idiopathic RPL. Among the six diagnostic markers, in terms of predicting pregnancy outcomes with IVIG treatment, CD3<jats:sup>+<\/jats:sup>IL\u201017<jats:sup>+<\/jats:sup> T cell\/CD4<jats:sup>+<\/jats:sup>Foxp3<jats:sup>+<\/jats:sup> T cell ratio was the most valuable prognostic marker. In RPL women with high CD3<jats:sup>+<\/jats:sup>IL\u201017<jats:sup>+<\/jats:sup> T cell\/CD4<jats:sup>+<\/jats:sup>Foxp3<jats:sup>+<\/jats:sup> T cell ratio (\u2265 1.096), the live birth rate (LBR) was improved with IVIG treatment. (IVIG treatment, 78.57%\u00a0vs. no IVIG, 28.57%, <jats:italic>p<\/jats:italic> = 0.026). On the other hand, RPL women with low CD3<jats:sup>+<\/jats:sup>IL\u201017<jats:sup>+<\/jats:sup> T cell\/CD4<jats:sup>+<\/jats:sup>Foxp3<jats:sup>+<\/jats:sup> T cell ratio did not demonstrate the effectiveness of IVIG (LBRs with IVIG treatment, 50.00%\u00a0vs. no IVIG, 84.62%, <jats:italic>p<\/jats:italic> = 0.219). In a correlation study, the CD3<jats:sup>+<\/jats:sup>IL\u201017<jats:sup>+<\/jats:sup> T cell\/CD4<jats:sup>+<\/jats:sup>Foxp3<jats:sup>+<\/jats:sup> T cell ratio was an independent prognostic marker, showing no correlation with NKC, NK cell percentage, and Th1\/Th2 cell ratio.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The CD3<jats:sup>+<\/jats:sup>IL\u201017<jats:sup>+<\/jats:sup> T\/CD4<jats:sup>+<\/jats:sup>Foxp3<jats:sup>+<\/jats:sup> T cell ratio may serve as a valuable marker for understanding the pathogenesis of RPL, predicting pregnancy outcomes, and selecting candidates for immunotherapy. Our study demonstrates that IVIG treatment can significantly improve LBR in women with a high CD3<jats:sup>+<\/jats:sup>IL\u201017<jats:sup>+<\/jats:sup> T\/CD4<jats:sup>+<\/jats:sup>Foxp3<jats:sup>+<\/jats:sup> T ratio, offering a promising therapeutic approach for this challenging condition.<\/jats:p><\/jats:sec>","DOI":"10.1111\/aji.70020","type":"journal-article","created":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T10:04:56Z","timestamp":1732529096000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["IL\u201017 Producing T to Foxp3<sup>+<\/sup>CD4<sup>+<\/sup> Regulatory T Cell Ratio as a Diagnostic and Prognostic Marker in Women With Recurrent Pregnancy Loss and Its Implications for Intravenous Immunoglobulin Therapy"],"prefix":"10.1111","volume":"92","author":[{"given":"Jin\u2010Sol","family":"Park","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology Seoul National University Hospital  Seoul Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ah\u2010Yun","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology Konyang University Hospital  Daejeon Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju\u2010Young","family":"Bae","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology Konyang University Hospital  Daejeon Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Won","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology Konyang University Hospital  Daejeon Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Hyun","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology Konyang University Hospital  Daejeon Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chul\u2010Jung","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology Konyang University Hospital  Daejeon Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6941-192X","authenticated-orcid":false,"given":"Sung Ki","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology Konyang University Hospital  Daejeon Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,11,25]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2019.11.025"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/hropen\/hoy004"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1472-6483(10)62018-4"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/der301"},{"issue":"2","key":"e_1_2_9_6_1","first-page":"76","article-title":"Recurrent Pregnancy Loss: Etiology, Diagnosis, and Therapy","volume":"2","author":"Ford H. B.","year":"2009","journal-title":"Reviews Obstetrics and Gynecology"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/aji.13627"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)92539-2"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/15.5.1163"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deg156"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.2008.00596.x"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.1996.tb00495.x"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/aji.12137"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.2012.01135.x"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20041257"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.8.5737"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2004.01869.x"},{"issue":"2","key":"e_1_2_9_18_1","first-page":"213","article-title":"The T Helper Type 17\/Regulatory T Cell Paradigm in Pregnancy (vol 148, pg 13, 2016)","volume":"156","author":"Figueiredo A. S.","year":"2019","journal-title":"Immunology"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.2147\/IJWH.S455733"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2024.104290"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.2010.00921.x"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2009.12.003"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.4.2572"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.2011.00992.x"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/aji.12442"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/der301"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.14674"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2023.104170"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2012.11.019"},{"issue":"3","key":"e_1_2_9_30_1","first-page":"256","article-title":"Evaluation of Th17 and Treg Cytokines in Patients With Unexplained Recurrent Pregnancy Loss","volume":"8","author":"Farshchi M.","year":"2022","journal-title":"J Clinical and Translational Research"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2009.12.003"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/aji.13018"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2006.01201.x"},{"key":"e_1_2_9_34_1","unstructured":"Embryology ESoHRa.Guideline on the management of recurrent pregnancy loss www.eshre.eu\/guidelines;2023."},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.13192"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/aji.13737"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.5653\/cerm.2017.44.1.1"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/aji.12208"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2017.4574"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2017.10.003"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2023.103977"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101527"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7827-12-74"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2023.103818"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.2011.01018.x"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2020.103189"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.1995.tb01136.x"},{"issue":"2","key":"e_1_2_9_48_1","first-page":"154","article-title":"Immunoglobulin G Infusion Treatment for Women With Recurrent Spontaneous Abortions and Elevated CD56+ Natural Killer Cells","volume":"4","author":"Kwak J. Y.","year":"2000","journal-title":"Early Pregnancy"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00937"}],"container-title":["American Journal of Reproductive Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/aji.70020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T14:45:32Z","timestamp":1732545932000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/aji.70020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["10.1111\/aji.70020"],"URL":"https:\/\/doi.org\/10.1111\/aji.70020","archive":["Portico"],"relation":{},"ISSN":["1046-7408","1600-0897"],"issn-type":[{"value":"1046-7408","type":"print"},{"value":"1600-0897","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"2024-08-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70020"}}